Table 1 Baseline patient characteristics and history (NÂ =Â 82)
Characteristic | Usual care n = 41 | PtDA intervention n = 41 |
|---|---|---|
Age: mean (SD) | 67.2 (12.6) | 66.3 (9.4) |
Male | 30 (73.2) | 30 (73.2) |
Living with someone | 29 (70.3) | 38 (92.7) |
Education | ||
 High school | 20 (52.6) | 21 (55.3) |
 College/trade | 13 (34.2) | 14 (36.8) |
 University/graduate school | 5 (13.1) | 3 (7.9) |
Current employment status | ||
 Full-time/part-time | 4 (9.8) | 9 (22) |
 Retired | 27 (65.9) | 22 (53.7) |
 Disability | 10 (24.4) | 10 (24.4) |
Ethnicity | ||
 Caucasian | 36 (87.8) | 41 (100) |
 Other | 4 (9.8) | 0 (0.0) |
CES-D: mean (SD) | 16.6 (4.5) | 14.5 (6.2) |
SF36-v2: mean (SD) | ||
 MCS | 48.5 (12.6) | 51.4 (13.2) |
 PCS | 37.1 (7.7) | 36.7 (9.3) |
Cardiovascular history | ||
 Previous MI | 18 (43.9) | 21 (51.2) |
 Previous CABG | 8 (19.5) | 7 (17.1) |
 Previous stroke or TIA | 6 (14.6) | 4 (9.8) |
 Hypertension | 13 (31.7) | 15 (36.6) |
 Ischemic CAD | 26 (63.4) | 26 (63.4) |
 Non-ischemic | 12 (29.3) | 5 (12.2) |
 CHF history | 22 (53.7) | 29 (70.7) |
 Atrial fibrillation | 16 (39.0) | 7 (17.1) |
Ejection fraction mean (SD) comorbidities | 26.1 (4.4) | 27.8 (6.0) |
 Diabetes | 12 (29.3) | 24 (58.9) |
 COPD | 7 (17.1) | 6 (14.6) |
 Recorded NYHA (at referral) | ||
  Class I | 4 (9.8) | 4 (9.8) |
  Class II | 16 (39.0) | 16 (39.0) |
  Class III | 11 (26.8) | 8 (19.5) |
  Undocumented | 10 (24.4) | 13 (31.7) |
 Medication | ||
  ACE inhibitor | 28 (68.3) | 26 (63.4) |
  β-blocker | 35 (85.4) | 32 (78.1) |
  Ca2+ channel blocker | 5 (12.2) | 6 (14.6) |
  Diuretic | 28 (68.3) | 24 (58.5) |
  Insulin/diabetic medication | 11 (26.8) | 22 (53.7) |
  Lipid lowering agent | 28 (68.3) | 25 (61.0) |
  Anti-depressant | 6 (14.6) | 2 (4.9) |